Fernando Goldsztein, a father from the U.S., took drastic action after his son Frederico was diagnosed with medulloblastoma, a rare form of brain cancer. Despite the initial treatment and a relapse, Goldszstein has partnered with researchers to fund and coordinate international studies, aiming to improve survival rates for children with this aggressive disease. The initiative has supported clinical trials, including one that uses programmed white blood cells to attack tumors, showing promising results.
.